CRT 2026

Live Case Broadcasting From TBD | Location: TBD

Moderator(s)

• 

  Odayme Quesada, MD, MHS, FACC, FAHA, FESC

  Medical Director, Women’s Heart Center; Ginger Warner Endowed Chair in Women’s Cardiovascular Health; Assistant Professor of Internal Medicine, University of Cincinnati
  The Christ Hospital
  Cincinnati, Ohio, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Janet Wei, MD

  Associate Professor, Cardiology and Biomedical Sciences
  Cedars-Sinai Smidt Heart Institute

  Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

• 

  Sukhdeep S. Bhogal, MD

  Interventional Cardiologist
  Sovah Health
  Roanoke, Virginia, United States

  Disclosure(s): No financial relationships to disclose
• 

  William F. Fearon, MD

  Professor of Medicine Director, Interventional Cardiology
  Stanford University School of Medicine
  Stanford, California, United States

  Disclosure information not submitted.
• 

  Morton J. Kern, MD, MSCAI, FACC, FAHA

  Interventional Cardiologist
  VA Long Beach Health Care System
  Long Beach, California, United States

  Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• MP

  Megha Prasad, MD

  Assistant professor
  Columbia university

  Disclosure information not submitted.
• 

  Nathaniel R. Smilowitz, MD

  Assistant Professor of Medicine
  NYU Langone Health
  New York, New York, United States

  Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AngioInsight: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Pieter C. Smits, PhD, FESC

  Chief Medical Director
  CERC (Cardiovascular European Research Center)
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure information not submitted.
• 

  Todd C. Villines, MD

  Vice-Chair, Clinical Services and Professor of Medicine
  University of Virginia
  Charlottesville, Virginia, United States

  Disclosure(s): Abcentra: Consulting Fees (e.g., advisory boards) (Ongoing); Cleerly Health: Consulting Fees (e.g., advisory boards) (Ongoing); Heartflow, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Milestone Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Robert J. Widmer, MD, PhD

  Chief, The Heart Group, McKinney, TX
  Baylor Scott & White Health
  Fairview, Texas, United States

  Disclosure(s): AngioInsight: Consulting Fees (e.g., advisory boards) (Ongoing)